Clinical Trials Browser

Phase 1 × Completed × roniciclib × Clear all

NCT01188252 2017-01-09

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies

Phase 1 Completed

Neoplasms

NCT02390154 2016-07-15

Roniciclib Mass Balance Study

Phase 1 Completed

Neoplasms

NCT02457351 2016-05-23

Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study

Phase 1 Completed

Medical Oncology